Greenleaf Trust increased its holdings in DuPont de Nemours, Inc. (NYSE:DD - Free Report) by 189.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 16,398 shares of the basic materials company's stock after purchasing an additional 10,726 shares during the quarter. Greenleaf Trust's holdings in DuPont de Nemours were worth $2,130,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the company. Center for Financial Planning Inc. grew its holdings in DuPont de Nemours by 19.7% during the 3rd quarter. Center for Financial Planning Inc. now owns 607 shares of the basic materials company's stock worth $79,000 after acquiring an additional 100 shares during the period. Brandywine Oak Private Wealth LLC increased its stake in DuPont de Nemours by 0.9% during the 3rd quarter. Brandywine Oak Private Wealth LLC now owns 12,301 shares of the basic materials company's stock valued at $1,598,000 after purchasing an additional 111 shares in the last quarter. Americana Partners LLC lifted its position in DuPont de Nemours by 0.4% in the 3rd quarter. Americana Partners LLC now owns 24,855 shares of the basic materials company's stock valued at $3,228,000 after acquiring an additional 111 shares in the last quarter. Delta Capital Management LLC boosted its position in shares of DuPont de Nemours by 1.1% during the third quarter. Delta Capital Management LLC now owns 13,620 shares of the basic materials company's stock valued at $1,769,000 after buying an additional 143 shares during the last quarter. Finally, Physician Wealth Advisors Inc. boosted its holdings in DuPont de Nemours by 223.1% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 210 shares of the basic materials company's stock worth $27,000 after acquiring an additional 145 shares during the last quarter. 73.96% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on DD shares. UBS Group reduced their price objective on DuPont de Nemours from $178.00 to $172.00 and set a "buy" rating for the company in a research note on Monday, October 5th. JPMorgan Chase & Co. lowered shares of DuPont de Nemours from an "overweight" rating to a "neutral" rating and reduced their price objective for the company from $172.00 to $145.00 in a research note on Friday, October 9th. Royal Bank Of Canada reduced their price objective on shares of DuPont de Nemours from $176.00 to $160.00 and set an "outperform" rating for the company in a research note on Thursday, October 15th. Citigroup lowered their target price on shares of DuPont de Nemours from $170.00 to $162.00 and set a "buy" rating on the stock in a report on Wednesday, October 7th. Finally, Weiss Ratings restated a "sell (d+)" rating on shares of DuPont de Nemours in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $162.00.
View Our Latest Report on DD
DuPont de Nemours Trading Up 0.8%
Shares of DuPont de Nemours stock opened at $141.21 on Tuesday. The company's 50-day moving average price is $132.31 and its 200-day moving average price is $138.39. The company has a current ratio of 2.43, a quick ratio of 1.82 and a debt-to-equity ratio of 0.23. DuPont de Nemours, Inc. has a 12-month low of $100.00 and a 12-month high of $157.98. The company has a market cap of $19.07 billion, a price-to-earnings ratio of 313.86, a PEG ratio of 1.28 and a beta of 1.05.
DuPont de Nemours (NYSE:DD - Get Free Report) last posted its earnings results on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.76 by $0.12. The business had revenue of $1.82 billion for the quarter, compared to analysts' expectations of $1.81 billion. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. The business's revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.12 EPS. On average, equities analysts expect that DuPont de Nemours, Inc. will post 7.25 earnings per share for the current fiscal year.
DuPont de Nemours Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, November 30th will be paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Monday, November 30th. DuPont de Nemours's dividend payout ratio is currently 533.33%.
DuPont de Nemours Profile
(
Free Report)
DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.
The company's product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DuPont de Nemours, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.
While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.